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The γ-aminobutyric acid-A receptor (GABA A R) is the predominant inhibitory receptor in the nervous system (Macdonald and Olsen, 1994) . The receptor is composed of protein subunits (α, β, γ, δ, ε, ρ, θ, and π) (Barnard et al., 1998; Bonnert et al., 1999) that are arranged in a pentameric conformation (Barnard et al., 1998) . Once activated by the ligand GABA, the protein changes its conformational structure from a
closed to an open state, allowing Cl -ions into the cell. GABA A Rs are members of the ligand-gated ion channel superfamily, which include glycine receptors, 5-HT 3 receptors, and the nicotinic acetylcholine receptors (Ortells and Lunt, 1995) . Several classes of compounds bind to the receptor and influence the channel's action. These include the benzodiazepines, steroids, barbiturates, and the convulsant picrotoxin (Hevers and Luddens, 1998) .
A novel class of compounds that regulate the GABA A receptor are the γ-butyrolactones (GBLs) and the related γ-thiobutyrolactones (TBLs). The lactones have either positive or negative modulatory activity, depending on the substitution incorporated in the lactone ring. These compounds have been substituted with alkyl groups (Mathews et al., 1996) and fluorinated groups (Canney et al., 1998) . The presence of relatively small substituents at the α-position generally results in anticonvulsant activity and potentiation of GABA-gated Cl -current, whereas lactones with larger substituents at this position may display convulsant activity (Canney et al., 1991; Holland et al., 1992) . Alkyl substitution at the β-position results in convulsant activity and a decrease in GABA-activated current (Klunk et al., 1982b; Holland et al., 1990b; Yoon et al., 1993) , while unsubstituted γ-butyrolactone has no significant effect on GABA current (Feigenbaum and Howard, 1996) .
This article has not been copyedited and formatted. The final version may differ from this version. (Levine et al., 1985; Holland et al., 1990a) , it was concluded that the effects of lactones are due to binding at the picrotoxin site. Convulsant (GABA current inhibiting) or anti-convulsant (GABA current enhancing) activity was presumed to be due the ability of lactones to act as either positive or negative modulators, respectively, of the picrotoxin site (Holland et al., 1990a) .
Subsequent studies led to the belief that the inhibitory effects of the lactones are in fact due to an interaction at the picrotoxin site (Yoon et al., 1993; Williams et al., 1997) , but that the positive modulatory actions are due to action at a "lactone site" (Holland et al., 1995; Williams et al., 1997) .
Whether or not a true lactone binding site exists on the GABA A R is unknown. It is possible, for example, that the GABA current-enhancing effects of lactones are secondary to relatively non-selective alterations of the local physio-chemical environment, which could subsequently influence GABA A R activity. One approach to provide evidence of a ligand binding site is demonstration of enantioselective preference. Enantiomers are non-superimposible mirror images of optically active molecules (i.e., compounds with at least one chiral center). They have identical physiochemical properties, and thus any effects of them due to alterations of membrane lipids would be identical (Arnett et al., 1982; Guyer et al., 1983; Mannock et al., 2003; Westover et al., 2003) . Targets that display an enantioselective preference are thus likely to have a specific binding site for the parent molecule. GABA A Rs have been shown to display enantioselective interactions with several compounds. These include 6 the volatile anesthetics halothane (Harris et al., 1998) and isoflurane (Hall et al., 1994) , barbiturates (Rho et al., 1996) and neurosteroids (Covey et al., 2001 ).
To more definitively evaluate the possibility that a lactone binding site exists on the GABA A R, we have synthesized enantiomers of a novel butyrolactone, α-benzyl-α-methyl-γ-butyrolactone (α-BnMeGBL), and studied its actions using in vitro and in vivo
approaches. Our results demonstrate that α-BnMeGBL enantioselectively interacts with GABA A receptors, and provide the strongest evidence to date in support of the existence of a lactone binding site on GABA A Rs.
This article has not been copyedited and formatted. The final version may differ from this version. 1. An authentic sample of (S)-n-butyl 2-benzyl-2-methyl-3-benzoylpropionate was then prepared according to a literature procedure (Meyers, et al., 1990) . The benzoyl group of this ketoester was then oxidized with sodium perborate in refluxing trifluoroacetic acid to a phenyl ester group yielding (S)-2-benzyl-2-methylsuccinic acid phenyl ester, n-butyl ester. Reduction of this diester with lithium aluminum hydride gave Cloned GABA A Receptors. Human embryonic kidney cells stably transfected with rat α1β2γ2 GABA A receptors were studied in this investigation. Cells expressing these receptors were generously supplied by Pharmacia (Kalamazoo, MI). Preparation and culture of these cells has been previously described in detail (Hamilton et al., 1993) .
Separation of Racemic
Radioligand Binding. Competitive radioligand binding studies were conducted as described previously (Levine et al., 1985) . Briefly, Sprague-Dawley male rats were dissected and their cerebral hemispheres were isolated. Membrane fractions were made and stored at -70° until time of experiment. At the time of experiment, fractions were resuspended with a Polytron and protein concentration was determined. The assay consisted of 100 µl of tissue homogenate with 50 µl [
S]-TBPS (2 nM) in 1M
NaBr and 50 µl Tris-citrate buffer (pH 7.5 at 0°) containing either no additive or varying concentrations of either enantiomer of α-BnMeGBL. The samples were incubated at 25°C for 90 min., followed by dilution with 3 ml 0.9% NaCl. Samples were filtered through Whatman GF/B microfiber filter discs with slight vacuum applied and washed twice with 3 ml 0.9% NaCl. Radioactivity was determined using conventional liquidscintillation counting. Non-specific binding was characterized with unlabeled 10 µM confidence intervals for ED 50 were determined graphically by reading off the graph the minimum and maximum drug concentrations offering 50% protection with 95% confidence (dose-response curve confidence intervals at 50% response).
Electrophysiology. The whole-cell patch clamp technique was used to record GABA-induced Cl -currents. Patch pipettes of borosilicate glass (1B150F, World Precision Instruments, Inc., Sarasota, FL) were pulled (Flaming/Brown, P-87/PC, Sutter Instrument Co., Novato, CA) to a tip resistance of 1-2.5 MΩ when filled with the following pipette solution (in mM): 140 CsCl, 10 EGTA, 10 HEPES, 4 Mg-ATP; pH 7.2.
Coverslips containing cultured cells were placed in a small chamber (∼ 1.5 ml) on the observed, as the potency of the (+)-α-BnMeGBL was more than 2-fold greater than that observed with (-)-α-BnMeGBL (Table 1) . Fig. 2A) . Maximal enhancement of GABA current was roughly 2.5-fold of the control, and occurred at 2 mM (+)-α-BnMeGBL. The EC 50 and Hill coefficient were estimated to be 0.5 ± 0.08 mM and 1.3 ± 0.25, respectively. At the highest concentrations (at and above 1 mM), enhancement of current decay became apparent.
Effects of α-BnMeGBL
(-)-α-BnMeGBL also enhanced GABA-gated current in α1β2γ2 receptors (Fig.   2B ). Although the apparent affinity of the negative enantiomer (EC 50 = 0.22 ± 0.02 µM) was higher than that of (+)-α-BnMeGBL, it had roughly 50% of the efficacy observed with the (+) enantiomer. As seen with the (+) enantiomer, high concentrations of (-)-α-BnMeGBL elicited enhancement of current decay (Fig. 2B, anesthetics, in addition to allosterically modulating the GABA A R, can also directly activate the channel (Rho et al., 1996; Krasowski et al., 1998) . The ability of γ-butyrolactone compounds to directly activate the GABA A R has not been fully explored.
We thus evaluated whether enantiomers of α-BnMeGBL could directly open α1β2γ2 
Discussion
Despite extensive study, definitive evidence for the existence of a lactone binding site on the GABA A R has proven to be elusive. Whereas early studies led to the conclusion that both positive modulatory (GABA current enhancing) and negative modulatory (GABA current inhibiting) actions of the lactone compounds were due to an interaction at the picrotoxin site of the receptor (Holland et al., 1991) , subsequent work led to the suggestion that positive modulatory actions of lactones resulted from modulation of a novel site (Yoon et al., 1993; Holland et al., 1995) . The fact that both GABA current stimulatory and inhibitory effects of lactones are not due to differential modulation of a single site is best supported by the results of Williams et al. (1997) .
They showed that the ability of convulsant lactones to inhibit GABA-activated current was abolished by a mutation known to also abolish sensitivity to picrotoxin. However, the GABA current-enhancing effects of lactones could not be abolished by this mutation. the decrease in GABA current induced by α-BnMeGBL may be due to its facilitation of entry into the desensitized state. Finally, the existence of another low affinity inhibitory site for lactones cannot be ruled out. Williams et al. (1997) found that GABA A receptors expressing a mutation that rendered them insensitive to the inhibitory effects of µM β-EMTBL were still inhibited by higher concentrations (mM) of β-EMTBL.
Enantioselectivity of α-BnMeGBL. Although in the present studies we have characterized a novel anticonvulsant lactone, the major goal of this research was to evaluate whether enantiomers of this lactone had differential anticonvulsant and GABA A R modulating properties. Because enantioselective preference is typically considered to be evidence of a specific ligand-protein interaction (Bahr and Parsons, 1986; Bertucci et al., 1997) , assessment of this trait is a useful approach for evaluating whether a binding site for a particular molecule exists on a particular receptor. Our data clamp assays confirms the significance of the stereoselective effect. Although the overall magnitude of enantioselective preference appears relatively modest, this degree of enantioselectivity has been reported for other molecules, and does result in distinct functional effects (Hall et al., 1994; Cordato et al., 1999; Covey et al., 2000) .
Direct activation of GABA A Rs by α-BnMeGBL. In addition to allosterically modulating GABA-activated current, we demonstrate that α-BnMeGBL can also directly activate the α1β2γ2 GABA A receptor. Several butyrolactones and thiobutyrolactones have been tested for direct receptor activating effects, at concentrations from 1-10 mM, and they have not shown this characteristic (Holland et al., 1990a; Mathews et al., 1996) . Because of solubility issues we did not determine the maximal efficacy for the direct gating effects of α-BnMeGBL, and thus could also not fully assess if enantioselectivity for this effect existed. At 3 mM, the (+) and (-) enantiomers of α-BnMeGBL activated a current less than one-third the amplitude of current generated in response to 5 µM GABA (the EC 20 concentration in α1β2γ2 receptors). Thus, compared to other ligands that directly activate the receptor, the efficacy of α-BnMeGBL for direct channel activation may be modest (Rho et al., 1996; Gonzales et al., 2001) .
Considering that other lactones previously reported not to directly activate the receptor had smaller alkyl substituents than those present in α-BnMeGBL, the presence of a bulky side chain may be crucial in altering the GABA The results of the present study provide further evidence that positive modulatory actions of butyrolactones and thiobutyrolactones are due to interaction with a distinct protein binding site. Although we presume the binding site is located on the GABA A receptor itself, the possibility that lactones may be binding to an associated protein that regulates GABA A receptor function cannot be dismissed. Distinguishing between these two possibilities will require additional studies.
This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version.
